Here, we found that high mRNA levels of TEAD1 were observed in 0.4% of GC patients, and consistent with the previous studies, overexpression of TEAD1 positively correlated to poor prognosis in OS, FP, and PPS. This evidence concerns the gene TEAD1 and gastric cancer.